5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione Mesylate salt
AssigneeSmithKline Beecham Corporation
InventorsAndrew Craig, Tim Ho, Michael Millan, Deirdre O'Keeffe
Life of this patent
Estimating the term…
Abstract
Disclosed are 5-[4-[2-(N-Methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione mesylate salts, or solvates thereof; processes for preparing such compounds, compositions comprising such compounds and the use of such compounds in medicine.
Claims10
1-17. (canceled)
A compound, 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione mesylate, wherein said compound provides at least one of:
- (i) an infra red spectrum containing peaks at about 1549, 759, 600 cm−1;
- (ii) a Raman spectrum containing peaks at about 1338, 1183, 990, 552 cm−1;
- and
- (iii) an X-ray powder diffraction pattern containing peaks at about 6.2, 11.9, 15.9, 19.8, 22.7 °2θ.
A compound, 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione mesylate, wherein said compound provides at least one of:
- (i) in a mineral oil dispersion, an infra red spectrum substantially in accordance with FIG. 10:
- (ii) a Raman spectrum substantially in accordance with FIG. 11:
- (iii) an X-ray powder diffraction pattern substantially in accordance with FIG. 12:
- (iv) a solid state 13C NMR spectrum substantially in accordance with FIG. 13:
A compound, 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione mesylate, wherein said compound provides an FT infra red spectrum containing bands at 2771, 1747, 1698, 1646, 1613, 1587, 1550, 1512, 1478, 1451, 1422, 1388, 1335, 1314, 1239, 1153, 1110, 1032, 1008, 963, 911, 829, 816, 774, 758, 736, 713, 660 cm−1.
Dependencies are inferred from the claim text.